Determination of the complex between urokinase and its type-1 inhibitor in plasma from healthy donors and breast cancer patients.

MLA

Pedersen, A. N., et al. “Determination of the Complex between Urokinase and Its Type-1 Inhibitor in Plasma from Healthy Donors and Breast Cancer Patients.” Clinical Chemistry, vol. 45, no. 8 Pt 1, Aug. 1999, pp. 1206–13. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10430786&authtype=sso&custid=ns315887.

APA

Pedersen, A. N., Brünner, N., Høyer-Hansen, G., Hamer, P., Jarosz, D., Larsen, B., Nielsen, H. J., & Stephens, R. W. (1999). Determination of the complex between urokinase and its type-1 inhibitor in plasma from healthy donors and breast cancer patients. Clinical Chemistry, 45(8 Pt 1), 1206–1213.

Chicago

Pedersen, A N, N Brünner, G Høyer-Hansen, P Hamer, D Jarosz, B Larsen, H J Nielsen, and R W Stephens. 1999. “Determination of the Complex between Urokinase and Its Type-1 Inhibitor in Plasma from Healthy Donors and Breast Cancer Patients.” Clinical Chemistry 45 (8 Pt 1): 1206–13. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10430786&authtype=sso&custid=ns315887.